3D Printed Drugs Market Size, Growth, Share by 2031
The 3D Printed Drugs Market size is projected to reach US$ 83.08 million by 2031 from US$ 33.58 million in 2023. The market is expected to register a CAGR of 9.6% in 2023–2031. adoption of novel technologies in 3D drug printing to streamline procedural outcomes is likely to remain a key 3D printed drugs market trend.
3D Printed Drugs Market Analysis
A 3D printed drug is a pharmaceutical product manufactured using 3D printing technology, which creates a 3D solid from the digital file. 3D-printed drugs play a significant role in personalized medicine. The technology also assists in the study of tailored drug release profiles. It is referred to the digital file that contains information about the desired drug release profile for 3D-printed drugs. The profile contains the following information drug concentration, release rate and kinetics, time-dependent release profile, and material properties. This will help to develop personalized medicine with precise drug delivery, which leads to improved efficiency, enhanced patient compliance, and reduced side effects.
3D Printed Drugs Market Overview
3d printed drugs refer to pharmaceuticals initiated using 3D printing technology, which allows for the precise fabrication of complex structures and customized dosage. This approach offers various benefits like personalized medicine, complex geometries, rapid prototyping, on-demand production, and improved drug delivery. Spritam, ZipDose are some of the examples of 3D-printed drugs. The market's growth is ascribed to key driving factors, such as increasing awareness of 3D printing and extensively growing developments in 3D printing research. However, limited use due to illegal drug manufacturing is likely to show a negative impact on market growth during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
3D Printed Drugs Market: Strategic Insights
Market Size Value in US$ 28.52 Million in 2019 Market Size Value by US$ 57.03Million by 2027 Growth rate CAGR of 9.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
3D Printed Drugs Market: Strategic Insights
| Market Size Value in | US$ 28.52 Million in 2019 |
| Market Size Value by | US$ 57.03Million by 2027 |
| Growth rate | CAGR of 9.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
3D Printed Drugs Market Drivers and Opportunities
Increasing Prevalence of Dysphagia to Favor Market
The worldwide population is mounting, such that it is predicted that there will be 2 billion over the age of 65 years by 2050; the most significant proportional increase will be in those over the age of 85 years. Various epidemiologic reports indicate that the prevalence of dysphagia is common in older populations and children. According to the statistics of the CDC, over 795,000 people are getting affected by strokes in the US every year, wherein 50% of stroke patients are associated with swallowing disorders. Additionally, various neurological diseases are known to be associated with dysphagia. The porous structure of 3D-printed drugs makes them collapse easily in the oral cavity. Thus, this form of medication is helpful for patients who often have swallowing difficulties, which in turn is driving the market's growth during the forecast period.
Emerging Market in Developing Countries
3D printing technologies are widely used in many areas, including fashion, construction, aerospace, and many other industries. In the field of medicine, it is being used mainly in dentistry and tissue engineering. However, the use of 3D printing technology in the pharmaceutical field is relatively recent. Many business sectors are unleashing the power of 3D printing technology, and experts predict that 3D printed (3DP) medications will revolutionize the pharmaceutical sectors during the forecast period. There’s a real opportunity with precision medicine to scale and dial in dose size for a specific patient. Many drug companies see tremendous opportunity and greater flexibility in creating dosage forms that meet specific patient needs. For instance, Cincinnati-based Aprecia is a pharmaceutical company specializing in 3DP medicinal products. In addition, in Feb 2020, Merck and AMCM, Starnberg, Germany, announced a cooperation agreement to deal with the 3D printing of tablets. Such activities are projected to offer lucrative opportunities for 3D-printed drug manufacturers during the forecast period.
3D Printed Drugs Market Report Segmentation Analysis
Key segments that contributed to the derivation of the 3D printed drugs market analysis are type, application, and end user.
- Based on resin type, the 3D printed drugs market is divided into tablets, capsules, multi-drug implants, nanoparticles, solutions, and other dosage forms. The tablet segment held the largest share of the market in 2023; also, the same segment is anticipated to register the highest CAGR % in the market during the forecast period.
- By technology type, the market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi-solid extrusion (SSE). The zip dose segment held the largest share of the market in 2023.
3D Printed Drugs Market Share Analysis by Geography
The geographic scope of the 3D printed drugs market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America has dominated the 3D-printed drugs market. Growth in government and private funding on healthcare infrastructure, growing awareness about the drugs, and increased technological awareness in the pharmaceutical industry are among the few factors projected to accelerate the growth of the North America 3D printing drugs market. Several firms are undergoing extensive R&D expenses to boost market growth by making significant product developments and innovations. The market is viewing strategic firms and collaborations as a lucrative path toward expanding the market existence by leveraging the various skills and expertise of the other companies in the market. For instance, Organovo, a medical laboratory and research company, has been at the forefront of the R&D of 3D bioprinting in the country. In addition, the company is approaching the FDA in early 2020 with an investigative new drug (IND) application wherein its bio-printed liver tissue can be used for the treatment of rare diseases.
3D Printed Drugs Market Report Scope (KEEP THIS KEYWORD HERE FOR SHYAM)
“DO NOT ADD ANY TABLE HERE
”
3D Printed Drugs Market News and Recent Developments
The 3D printed drugs market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
- In October, 2023, Finnish healthtech company CurifyLabs has announced the launch first in the world GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines. CurifyLabs’ Pharma Kit, including automated 3D printing technology and printable pharmaceutical inks, enables wider adoption of personalised medicine, resulting in better future care for patients with different needs according to the company. (Source: CurifyLabs, Press Release)
- In September 2023, LSMU (Lithuanian University of Health Sciences)launches the first validated pharmaceutical 3D Printer. The new device sets a new course for innovation development in pharmaceutical technologies. It allows to produce personalised medicine tailored to each individual patient, increase the efficacy of medicines by combining several substances in a single tablet and reducing the side effects of medicines. (Source: LSMU, Press Release)
3D Printed Drugs Market Report Coverage and Deliverables
The “3D Printed Drugs Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:
- 3D Printed Drugs Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- 3D Printed Drugs Market trends
- Detailed PEST and SWOT analysis
- 3D Printed Drugs market analysis covering key market trends, Global and regional framework, major players, regulations, and recent market developments.
- 3D Printed DrugsIndustry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments.
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Dosage Forms ; Technology , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For